Evidence based Dermatology - part 5 pot
Evidence based Dermatology - part 5 pot
... separately. Seven studies
54 ,55 ,60,61,68,71,72
were conducted in schools; four at beaches
52 ,57 ,63,69
;
two at pools
52 , 75
and three in other recreational
settings.
62, 65, 67
; There were two studies ... increasing
knowledge and behaviour
52 ,54 ,56 ,59 ,61–64
and six
were successful in increasing solar potection,
either the use of shade, staying out of the sun or
the use of cloth...
Evidence based Dermatology - part 3 pot
...
19 95;
132
: 950 5.
25. Kerscher MJ, Hart H, Korting HC
et al
. In vivo assessment
of the atrophogenic potency of mometasone furoate, a
newly developed chlorinated potent topical
156
Evidence- based ... betamethasone-17-valerate cream and
0· 05% clobetasol-17-propionate cream.
Clin Pharmacol
1992;
42
: 159 –61.
28. Kerscher MJ, Korting HC. Topical glucocorticoids of the
non-fluorina...
Evidence based Dermatology - part 7 potx
... (continuous terbinafine)
186
142
48
64
56
86
43
56
49
51
250 mg/day
250 mg/day
250 mg/day
250 mg/day
250 mg/day
250 mg/day
250 mg/day
250 mg/day
250 mg/day
50 0 mg/day
12 wks
12 wks
3 months
4 months
12 ... violaceum
11·4% (4/ 35) ;
T. rubrum
22·8% (8/ 35) ;
M. canis
48 5% (17/ 35) ;
T. tonsurans
5 7% (2/ 35) ;
T. mentagrophytes
5 7% (2/ 35) ;
T. verrucosum
5 7% (2/ 35)
Te...
Cosmetic Dermatology - part 5 potx
... 5- fluoroura-
cil. Cutis 62: 283–2 85
56. Chun E, Lee JB, Lee KH (2004) Focal trichloroacetic
acid peel method for benign pigmented lesions in
dark-skinned patients. Dermatol Surg 30 :51 2 51 6
57 . ... 2001
19(3)4 05 11
58 . Rubin MG (19 95) Manual of chemical peels: super-
ficial and medium depth. Lipincott-Raven, Phila-
delphia
59 . Cook K, Cook W Jr (2000) Chemical peel of nonfa-
cia...
Evidence based Dermatology - part 1 doc
... Goeckerman
treatment, psoralen-UVA, methotrexate, ciclosporin
and anti-interleukin-2 receptor antibodies) and
10
Evidence- based Dermatology
Box 2.1 What evidence- based
dermatology is not
• Something ... standard review. For
26
Evidence- based Dermatology
What is evidence- based
dermatology?
Definitions
Sackett, a clinical epidemiologist and one of the
founders of modern...
Evidence based Dermatology - part 2 pptx
... but
60
Evidence- based Dermatology
76
Applying the external evidence back to the
patient sitting in front of you is perhaps one of
the most difficult and least discussed steps of
evidence- based ... of
incidence due to the exposure.
66
Evidence- based Dermatology
equivalent numbers of patients to triclosan in a
12-week crossover trial with 34 patients,
15
although no wash-out...
Evidence based Dermatology - part 4 docx
... (median 157 0 versus
54 30 mJ/cm
2
).
55
In another RCT (n = 53 ) in which
all participants received low-dose NBUVB
phototherapy, just under half were randomised
to receive calcipotriol ointment, 50 microgram/g
twice ... (interquartile
range 50 5 116) and 67 days (43–94⋅ 75) , with
medians of 19 (13 5 27 5) and 25 5 (17⋅2– 35 8)
treatments, respectively; relapse rates were similar
(193...
Evidence based Dermatology - part 6 ppsx
... Dermatol
1986;
14
:661–8.
58 . Sturm H. Bowen’s disease and 5- fluorouracil.
J Am Acad
Dermatol
1979;
1
:51 3–22.
390
Evidence- based Dermatology
Scenario 2
A woman in her 50 s presents with a large biopsy-
proven ...
2001;
44
: 253 –60.
52 . Dippel E, Schrag H, Goerdt S, Orfanos C. Extracorporeal
photopheresis and interferon-α in advanced cutaneous T-
cell lymphoma.
Lancet
1997;...
Evidence based Dermatology - part 8 pptx
... burning, particularly at weeks 4 and
55 8
Evidence- based Dermatology
(8/11 (73%) versus 8/14 (57 %); RR 1·27, CI
0·7–2·3; NNT 6, CI 0·4–1·4). An unpublished
community -based pragmatic RCT (2 75 people),
(SSL ... concurrent topical calcipotriol
potentiates the efficacy of PUVAsol (oral
54 6
Evidence- based Dermatology
Figure 40.1 Neck with irregular-shaped depigmented
areas in a...
Evidence based Dermatology - part 9 docx
... Laeger
1992;
154
: 256 1–3.
30. Nocker W, Diebschlag W, Lehmacher W. A 3-month,
randomized double-blind dose-response study with
O-(beta-hydroxyethyl)-rutoside oral solutions.
Vasa
1989;
18
:2 35 8.
31. ... Dose-response study with
O-(beta-hydroxyethyl)-rutoside oral solution.
Vasa
1987;
16
:3 65 9.
32. Bergqvist D, Hallbook T, Lindblad B, Lindhagen A. A
double-blind trial of O-(beta-hydr...